This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Quality of Care, Other  • Alert me on articles by topic

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: One of the points in my Commentary was that the measures being used in today's public reporting and pay-for-performance programs are rather primitive and rote. This is not anyone's fault. The existing measures accurately reflect the immature state of the science of quality measurement, which in turn is a manifestation of our chronic underinvestment in that science (largely because there was no market for it until recently).

Now that there is real skin in the quality measurement game, it will be vital to continue to refine the measures, striving to make them more relevant to the care of complex patients with multidimensional illness and to improve our understanding of case-mix adjustment to facilitate apples-to-apples comparisons of outcomes, such as mortality. The risk raised by Dr McGovern is real. If we all unquestioningly follow existing measures and fail to do the hard work of finding better ones, not only . . . [Full Text of this Article]

Robert M. Wachter, MD
bobw@medicine.ucsf.edu
Department of Medicine
University of California
San Francisco